m
Recent Posts
Connect with:
Monday / November 16.
Homeminews (Page 719)

Medicines Australia has called for a long-term vision for health with strong investments in the PBS, science and innovation to ensure faster access for

Luxturna (voretigene neparvovec, Novartis), is now funded for the treatment of patients living with an inherited retinal disease (IRD) caused by pathological biallelic RPE65

Innoveyes – ray tracing technology that measures and combines data to generate a multi-dimensional model of the eye for truly individualised laser eye treatment

Glaucoma Australia’s Chief Executive Officer, Annie Gibbins, has resigned to pursue new opportunities.

DECLARATION

DISCLAIMER : THIS WEBSITE IS INTENDED FOR USE BY HEALTHCARE PROFESSIONALS ONLY.
By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.